Olezarsen cuts triglycerides up to 60%, normalizing levels in 85% of high-risk patients.
Baxdrostat lowers BP in resistant hypertension, offering a new treatment option.
Metabolic syndrome raises Parkinson’s risk by 39%, especially with genetic predisposition.
Oral testosterone undecanoate (Jatenzo) boosted T levels & sexual function in 92% of hypogonadal men by day 105 in phase 3 trial.
A recent study presented at the Musculoskeletal Infection Society Annual Meeting (Aug. 1–2, 2025, Jersey City, N.J.) highlighted the benefits of implementing a standardized protocol for managing periprosthetic joint …
FDA approves Vizz™—the first once-daily eye drop for presbyopia. Fast onset (30 mins), long-lasting (10 hrs), no myopic shift. Backed by CLARITY trials with 96% near-vision improvement. Designed for active lifestyles.
#EyeHealth #VizzDrop
🧠 A major study shows the MIND diet may cut Alzheimer’s risk by up to 25%, with greatest benefit seen in those improving diet over time. Results vary by ethnicity, highlighting need for culturally adapted plans. #BrainHealth #MINDdiet
Moderate coffee (1–2 cups/day) may lower risks of hypertension, diabetes, heart attack, AF, and early death via anti-inflammatory and metabolic benefits. Filtered coffee is best, as unfiltered can raise LDL. Caffeine may trigger PVCs in some but is generally heart-safe.
